Peak Pharmaceuticals (OTCMKTS:PKPH) Stock Price Down 3.2% – Here’s What Happened

Peak Pharmaceuticals, Inc. (OTCMKTS:PKPHGet Free Report) traded down 3.2% during trading on Tuesday . The stock traded as low as $0.77 and last traded at $1.21. 11,145 shares changed hands during trading, an increase of 23% from the average session volume of 9,053 shares. The stock had previously closed at $1.25.

Peak Pharmaceuticals Stock Up 45.3 %

The company’s fifty day moving average is $2.17 and its 200-day moving average is $2.94.

Peak Pharmaceuticals Company Profile

(Get Free Report)

Peak Pharmaceuticals, Inc manufactures and markets pharmaceutical level products containing phytocannabinoids, an abundant and pharmaceutically active component of industrial hemp for the prevention and alleviation of various conditions and diseases. The company was founded on December 18, 2007 and is headquartered in Scottsdale, AZ.

Featured Stories

Receive News & Ratings for Peak Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Peak Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.